Humana Inc. (HUM)
| Market Cap | 46.40B +57.3% |
| Revenue (ttm) | 137.20B +14.1% |
| Net Income | 1.13B -33.9% |
| EPS | 9.36 -33.9% |
| Shares Out | 120.06M |
| PE Ratio | 41.30 |
| Forward PE | 36.59 |
| Dividend | $3.54 (0.92%) |
| Ex-Dividend Date | Jun 26, 2026 |
| Volume | 2,288,962 |
| Open | 424.54 |
| Previous Close | 407.78 |
| Day's Range | 385.22 - 428.88 |
| 52-Week Range | 163.11 - 428.88 |
| Beta | 0.72 |
| Analysts | Hold |
| Price Target | 339.83 (-12.07%) |
| Earnings Date | Jul 29, 2026 |
About HUM
Humana Inc. provides medical and specialty insurance products in the United States. It operates in two segments, Insurance and CenterWell. The Insurance segment offers individual Medicare Advantage products, including health insurance benefits, including wellness programs, chronic care management, and care coordination; individual Medicare stand-alone prescription drug products (PDP); group Medicare advantage and Medicare stand-alone PDP; Medicare supplements; specialty and ancillary insurance comprising dental, vision, life and disability; and... [Read more]
Financial Performance
In 2025, Humana's revenue was $129.66 billion, an increase of 10.11% compared to the previous year's $117.76 billion. Earnings were $1.19 billion, a decrease of -1.57%.
Financial StatementsAnalyst Summary
According to 26 analysts, the average rating for HUM stock is "Hold." The 12-month stock price target is $339.83, which is a decrease of -12.07% from the latest price.
News
UnitedHealth Earnings Crush Estimates and Give These Stocks a Boost
The healthcare giant posts better-than-expected second-quarter earnings and hikes its full-year guidance.
Humana price target raised to $350 from $211 at TD Cowen
TD Cowen raised the firm’s price target on Humana (HUM) to $350 from $211 and keeps a Hold rating on the shares. The firm adjusted targets in the healthcare facilities…
Humana price target raised to $415 from $320 at Truist
Truist analyst David MacDonald raised the firm’s price target on Humana (HUM) to $415 from $320 and keeps a Hold rating on the shares as part of a broader research…
Humana upgraded to Overweight from Equal Weight at Wells Fargo
Wells Fargo analyst Stephen Baxter upgraded Humana (HUM) to Overweight from Equal Weight with a price target of $502, up from $227. The firm expects “constructive” Q2 earnings reports from…
Humana price target raised to $415 from $246 at RBC Capital
RBC Capital raised the firm’s price target on Humana (HUM) to $415 from $246 and keeps a Sector Perform rating on the shares as part of a broader research note…
Humana price target raised to $300 from $264 at Cantor Fitzgerald
Cantor Fitzgerald analyst Sarah James raised the firm’s price target on Humana (HUM) to $300 from $264 and keeps a Neutral rating on the shares. Cantor prefers payors over providers…
Did Humana Inc. Insiders Breach their Fiduciary Duties to Shareholders?
Shareholders are encouraged to contact the firm to discuss their rights and options at no cost or obligation. We would handle any matter on a contingent fee basis, whereby you would not be responsible...
The Humana Foundation Deepens Investment in Emotional Health, Announcing Over $12 Million in New Grants
LOUISVILLE, Ky.--(BUSINESS WIRE)--The Humana Foundation, the philanthropic arm of Humana Inc. (NYSE: HUM) for the past 45 years, today announced its first slate of 2026 grants, dedicating over $12.2 m...
Swedish care provider Ambea makes recommended $304 million offer for Humana
Swedish care provider Ambea said on Monday it had made a recommended public offer for peer Humana , valuing the company at about 2.96 billion Swedish crowns ($304.13 million).
Humana price target raised to $380 from $340 at BofA
BofA raised the firm’s price target on Humana (HUM) to $380 from $340 and keeps a Neutral rating on the shares. As the firm gets more comfortable with cost trend…
Humana Inc. to Release Second Quarter 2026 Results on July 29, 2026
LOUISVILLE, Ky.--(BUSINESS WIRE)--Humana Inc. (NYSE: HUM) will release its financial results for the second quarter 2026 (2Q26), as well as prepared management remarks (in PDF format), at 6:00 a.m. Ea...
The Big 3: HUM, BAC, MSFT
@Theotrade's Don Kaufman walks us through today's Big 3 and offers example options trades for his picks. He points to Humana (HUM) as a great bearish opportunity in the weeks to come, Bank of America...
Humana selected by Illinois Department of HFS to serve members statewide
Humana (HUM) has been selected by the Illinois Department of Healthcare and Family Services, HFS, to serve members statewide in HealthChoice Illinois, the state’s Medicaid managed care program. “It’s ...
Humana Awarded Statewide Illinois HealthChoice Medicaid Contract, Expanding Access to Care Across the State
LOUISVILLE, Ky.--(BUSINESS WIRE)--Humana Awarded Statewide Illinois HealthChoice Medicaid Contract, Expanding Access to Care Across the State.
Humana, CenterWell and National Hispanic Medical Association Announce 2026 Resident Physician Scholarship Program Recipients
LOUISVILLE, Ky.--(BUSINESS WIRE)--Humana, CenterWell and National Hispanic Medical Association announce 2026 Resident Physician Scholarship Program recipients.
Humana Investigation Continued: Kahn Swick & Foti, LLC Continues to Investigate the Officers and Directors of Humana Inc. - HUM
NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti, LLC (“KSF”), announces that KSF continues its investigat...
Report shows Medicare plans often deny access to special care, NY Times says
According to new reports from the inspector general’s office at the Department of Health and Human Services focusing on major health insurers, UnitedHealth (UNH), Humana (HUM), and CVS Health (CVS),…
Humana To Divest End-Of-Life Care Business For $900 Million
Humana, one of the nation's largest providers of privatized Medicare Advantage health insurance for older adults, announced plans to divest its minority stake in a provider of end-of-life services for...
Humana divests minority stake in hospice provider Gentiva
Humana said on Wednesday it has agreed to sell all or substantially all of its minority stake in Gentiva, a provider of hospice and palliative care services, in a deal valuing the stake at about $9...
Humana to divest minority interest in Gentiva to consortium of investors
Humana (HUM) announced that it has signed a definitive agreement with a consortium of investors to divest all or substantially all of its minority interest in Gentiva, a provider of…
Humana Announces Agreement to Divest Minority Interest in Gentiva
LOUISVILLE, Ky.--(BUSINESS WIRE)--Humana Inc. (NYSE: HUM) today announced that it has signed a definitive agreement with a consortium of investors to divest all or substantially all of its minority in...
Humana and CenterWell Employees Donate More Than $1.4 Million in 24 Hours
LOUISVILLE, Ky.--(BUSINESS WIRE)--Humana and CenterWell employees combined to donate more than $1.4 million to nonprofit organizations in just 24 hours during the Humana Foundation's annual Double Mat...
As Tech Stocks Slide, The Healthcare Sector Shines. Why Some Experts Say They Like This Defensive Play
Tech stocks are pulling back, and healthcare is surging.
Humana price target raised to $316 from $214 at JPMorgan
JPMorgan analyst Lisa Gill raised the firm’s price target on Humana (HUM) to $316 from $214 and keeps a Neutral rating on the shares. The firm updated healthcare service models.